Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Uncovering early, lineage-dependent effects of TPMT genotype in adult acute lymphoblastic leukemia by minimal residual disease. [electronic resource] by
- Raff, T
- Kaiser, M
- Gökbuget, N
- Lüschen, S
- Ritgen, M
- Trautmann, H
- Reutzel, R
- Hoelzer, D
- Kneba, M
- Brüggemann, M
Producer: 20130604
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
8.
|
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial. [electronic resource] by
- Ritgen, M
- Böttcher, S
- Stilgenbauer, S
- Bunjes, D
- Schubert, J
- Cohen, S
- Humpe, A
- Hallek, M
- Kneba, M
- Schmitz, N
- Döhner, H
- Dreger, P
Producer: 20080826
In:
Leukemia vol. 22
Availability: No items available.
|
|
|
9.
|
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis. [electronic resource] by
- Böttcher, S
- Stilgenbauer, S
- Busch, R
- Brüggemann, M
- Raff, T
- Pott, C
- Fischer, K
- Fingerle-Rowson, G
- Döhner, H
- Hallek, M
- Kneba, M
- Ritgen, M
Producer: 20091207
In:
Leukemia vol. 23
Availability: No items available.
|
|
|
10.
|
Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in. [electronic resource] by
- Goede, V
- Fischer, K
- Busch, R
- Jaeger, U
- Dilhuydy, M-S
- Wickham, N
- De Guibert, S
- Ritgen, M
- Langerak, A W
- Bieska, G
- Engelke, A
- Humphrey, K
- Wenger, M
- Hallek, M
Producer: 20130719
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
11.
|
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG). [electronic resource] by
- Wendtner, C-M
- Ritgen, M
- Schweighofer, C D
- Fingerle-Rowson, G
- Campe, H
- Jäger, G
- Eichhorst, B
- Busch, R
- Diem, H
- Engert, A
- Stilgenbauer, S
- Döhner, H
- Kneba, M
- Emmerich, B
- Hallek, M
Producer: 20040623
In:
Leukemia vol. 18
Availability: No items available.
|
|
|
12.
|
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia. [electronic resource] by
- Brüggemann, M
- van der Velden, V H J
- Raff, T
- Droese, J
- Ritgen, M
- Pott, C
- Wijkhuijs, A J
- Gökbuget, N
- Hoelzer, D
- van Wering, E R
- van Dongen, J J M
- Kneba, M
Producer: 20040503
In:
Leukemia vol. 18
Availability: No items available.
|
|
|
13.
|
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders. [electronic resource] by
- Ladetto, M
- Brüggemann, M
- Monitillo, L
- Ferrero, S
- Pepin, F
- Drandi, D
- Barbero, D
- Palumbo, A
- Passera, R
- Boccadoro, M
- Ritgen, M
- Gökbuget, N
- Zheng, J
- Carlton, V
- Trautmann, H
- Faham, M
- Pott, C
Producer: 20140729
In:
Leukemia vol. 28
Availability: No items available.
|
|
|
14.
|
Residual abdominal lymphadenopathy after intensive frontline chemoimmunotherapy is associated with inferior outcome independently of minimal residual disease status in chronic lymphocytic leukemia. [electronic resource] by
- Fürstenau, M
- Bahlo, J
- Fink, A M
- Lange, E
- Dreger, P
- Dreyling, M
- Hess, G
- Ritgen, M
- Kneba, M
- Döhner, H
- Stilgenbauer, S
- Wendtner, C M
- Goede, V
- Fischer, K
- Böttcher, S
- Hallek, M
- Eichhorst, B
Producer: 20200824
In:
Leukemia vol. 34
Availability: No items available.
|
|
|
15.
|
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL. [electronic resource] by
- Maurer, C
- Langerbeins, P
- Bahlo, J
- Cramer, P
- Fink, A M
- Pflug, N
- Engelke, A
- von Tresckow, J
- Kovacs, G
- Stilgenbauer, S
- Wendtner, C-M
- Müller, L
- Ritgen, M
- Seiler, T
- Fischer, K
- Hallek, M
- Eichhorst, B
Producer: 20170807
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
16.
|
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL. [electronic resource] by
- Rawstron, A C
- Böttcher, S
- Letestu, R
- Villamor, N
- Fazi, C
- Kartsios, H
- de Tute, R M
- Shingles, J
- Ritgen, M
- Moreno, C
- Lin, K
- Pettitt, A R
- Kneba, M
- Montserrat, E
- Cymbalista, F
- Hallek, M
- Hillmen, P
- Ghia, P
Producer: 20130228
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
17.
|
Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials. [electronic resource] by
- Al-Sawaf, O
- Robrecht, S
- Bahlo, J
- Fink, A M
- Cramer, P
- V Tresckow, J
- Lange, E
- Kiehl, M
- Dreyling, M
- Ritgen, M
- Dürig, J
- Tausch, E
- Schneider, C
- Stilgenbauer, S
- Wendtner, C M
- Fischer, K
- Hallek, M
- Eichhorst, B
Producer: 20210113
In:
Leukemia vol. 35
Availability: No items available.
|
|
|
18.
|
Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia. [electronic resource] by
- Elter, T
- James, R
- Busch, R
- Winkler, D
- Ritgen, M
- Böttcher, S
- Kahl, C
- Gassmann, W
- Stauch, M
- Hasan, I
- Staib, P
- Fischer, K
- Fink, A-M
- Bahlo, J
- Bühler, A
- Döhner, H
- Wendtner, C-M
- Stilgenbauer, S
- Engert, A
- Hallek, M
Producer: 20130212
In:
Leukemia vol. 26
Availability: No items available.
|
|
|
19.
|
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse. [electronic resource] by
- Hahn, M
- Böttcher, S
- Dietrich, S
- Hegenbart, U
- Rieger, M
- Stadtherr, P
- Bondong, A
- Schulz, R
- Ritgen, M
- Schmitt, T
- Tran, T H
- Görner, M
- Herth, I
- Luft, T
- Schönland, S
- Witzens-Harig, M
- Zenz, T
- Kneba, M
- Ho, A D
- Dreger, P
Producer: 20160819
In:
Bone marrow transplantation vol. 50
Availability: No items available.
|
|
|
20.
|
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. [electronic resource] by
- Fink, A M
- Böttcher, S
- Ritgen, M
- Fischer, K
- Pflug, N
- Eichhorst, B
- Wendtner, C-M
- Winkler, D
- Bühler, A
- Zenz, T
- Staib, P
- Mayer, J
- Hensel, M
- Hopfinger, G
- Wenger, M
- Fingerle-Rowson, G
- Döhner, H
- Kneba, M
- Stilgenbauer, S
- Busch, R
- Hallek, M
Producer: 20131021
In:
Leukemia vol. 27
Availability: No items available.
|